Skip to main content

TWi T085 225 (Propafenone Hydrochloride Extended-Release 225 mg)

Pill with imprint TWi T085 225 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 225 mg. It is supplied by TWi Pharmaceuticals USA, Inc..

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TWi T085 225

Propafenone Hydrochloride Extended-Release

Imprint
TWi T085 225
Strength
225 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group i antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
TWi Pharmaceuticals USA, Inc.
Manufacturer
TWi Pharmaceuticals, Inc.
National Drug Code (NDC)
24979-0085

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.